Purdue Pharma has tentatively reached a partial settlement for more than 2,000 opioid lawsuits. The deal is worth $10 billion to $12 billion, including $3 billion from the Sackler family itself. Some states have yet to approve the proposal. (MM&M)

Health and Human Services Secretary Alex Azar said on Wednesday that the Trump administration is considering a ban on flavored e-cigarettes. The Food and Drug Administration is preparing the guidance as an outbreak of a vaping-linked illness has left hundreds sick and six dead. The Centers for Disease Control and Prevention is investigating the mysterious lung disease, which could be related to vitamin E oil in vaping products. (MM&M)

Recently uncovered legal files showed Merck was aware of possible side effects of hair-loss drug Propecia, according to an investigation by Reuters. More than 1,100 lawsuits filed have argued that Merck did not adequately warn patients that the treatment could cause depression and other issues. (Reuters)

Amazon’s PillPack can no longer access patient medication history via its deal with ReMy Health, a company that previously gained that information from Surescripts. ReMy Health’s deal with Surescripts was terminated this week over a patient data dispute. PillPack will have to rely on patients to share their prescription history. (CNBC)

On this week’s episode of The MM&M Podcast, Mark Bard, cofounder of the Digital Health Coalition, puts Gallup poll results about the unpopularity of marketing in context. He also shares related data from a recent DHC benchmarking study of 20 pharma companies and provides a rundown on trends to keep an eye on. (MM&M)